Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_05032
Species: Homo sapiens
Position : chr21:40003867-40015913
Year: 2018
Title: Selective dissociation between LSD1 and GFI1B by a LSD1 inhibitor NCD38 induces the activation of ERG super-enhancer in erythroleukemia cells.
Genome Build: hg19
Enhancer Type: Super-enhancer
Condition: Disease
Disease Name: Leukemia
PMID:  29765516
Tissue: blood / hematopoietic system
Tissue Ontology ID: UBERON:0000178
Cell Source: HEL
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: TF-binding/chromatin assay; Disease-associated enhancer analysis
High Throughput Method: ChIP-seq
Low Throughput Method: ChIP-qPCR/ChIP; RT-qPCR/qPCR
About Target Gene
Target gene : ERG
About TF
TF name : KDM1A
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
KDM1A Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 reactome 65
KDM1A AndrogenReceptor netpath 167
KDM1A Coregulation of Androgen receptor activity pid 61
KDM1A Factors involved in megakaryocyte development and platelet production reactome 111
KDM1A HDACs deacetylate histones reactome 94
KDM1A HDMs demethylate histones reactome 49
KDM1A Notch-mediated HES/HEY network pid 48
KDM1A Notch signaling pathway pid 58
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_04012 chr21:40000000-40800000 heart cardiac muscle cell NA
E_05031 chr21:40003867-40015913 blood / hematopoietic system malignant cell Leukemia
E_05033 chr21:40003867-40015913 blood / hematopoietic system malignant cell Leukemia
Expression of Target Genes for the Enhancer